Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida
- 1 October 1995
- journal article
- Published by Elsevier in The Lancet
- Vol. 346 (8982), 1070-1071
- https://doi.org/10.1016/s0140-6736(95)91743-8
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis?The Lancet, 1995
- Three Different Methods for the Determination of Total Homocysteine in PlasmaAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1995
- Homocysteine metabolism in pregnancies complicated by neural-tube defectsThe Lancet, 1995
- Maternal hyperhomocysteinemia: A risk factor for neural-tube defects?Metabolism, 1994
- Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identificationNature Genetics, 1994
- Prevention of the First Occurrence of Neural-Tube Defects by Periconceptional Vitamin SupplementationNew England Journal of Medicine, 1992
- Prevention of neural tube defects: Results of the Medical Research Council Vitamin StudyThe Lancet, 1991